Inventor · disambiguated record
Mary J. Tanga
Also filed as: TANGA MARY J · TANGA MARY JEAN
6 granted patents·4 pending applications·43 citations·filing 2008–2025
79Inventor score
Files withTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC2US HEALTH2WYSS CORAY ANTON2BEAULIEU LAURA ELLEN DOWNS1COOPER HEALTH SYSTEM1
Top patents by PatentIndex Score
10 records- 0192US9867830B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2016·Granted Jan 16, 2018·12 cites·11 claims
- 0292US9650352B2Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic painCOOPER HEALTH SYSTEM·Filed 2012·Granted May 16, 2017·27 cites·22 claims
- 0377US2025319092A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2025·Application pending·0 cites
- 0474US8097645B2Compounds for activating TGF-β signalingWYSS-CORAY ANTON·Filed 2008·Granted Jan 17, 2012·2 cites·13 claims
- 0572US8410138B2Compounds for activating TGF-beta signalingWYSS-CORAY ANTON·Filed 2011·Granted Apr 2, 2013·2 cites·16 claims
- 0668US2020360393A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)-ketamine in the treatment of depression and neuropathic painTHE US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVIC·Filed 2020·Application pending·0 cites
- 0759US2018098993A1Use of (2r, 6r)-hydroxynorketamine, (s)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (r,s)- ketamine in the treatment of depression and neuropathic painUS HEALTH·Filed 2017·Application pending·0 cites
- 0858US9796674B2Benzyl urea derivatives for activating TGF-beta signalingUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Oct 24, 2017·0 cites·5 claims
- 0949US2014162309A1Arsenical Fluorescent Agents and AssaysSTANFORD RES INST INT·Filed 2014·Application pending·0 cites
- 1037US8664009B2Arsenical fluorescent agents and assaysBEAULIEU LAURA ELLEN DOWNS·Filed 2011·Granted Mar 4, 2014·0 cites·19 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →